Skip to content
Boca Raton City Online – Lifestyle
Author:
COUR Pharma
COUR Pharma Announces Closing of $50 Million Series B
June 18, 2026
COUR Pharma Announces Positive One-Year Results from the Phase 2a Study of CNP-104 in Primary Biliary Cholangitis
March 9, 2026